Browse studies

Find your next paid study

56 recruiting studies matching your filters

Mothers and CareGivers Investing in Children: MAGIC 2.0

The study will use a longitudinal, randomized control trial design to determine intervention impact on parent and child behaviors, and infant health. The two i…

Childhood Obesity PreventionParenting BehaviorInfant Growth

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Texas at AustinNCT06719102

Observational Study of Urine Metabolites in the Diagnosis of Disease

The goal of this observational study is to validate a non-invasive, urine-based diagnostic technology for the detection and differentiation of various gastroin…

Colorectal CancerSmall Intestinal Bacterial Overgrowth Syndrome (SIBO)Crohn Disease+1 more

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Luventix, Inc.NCT06710067

Phase 3

CSP #2018 - Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)

The purpose of this study is to determine whether growth hormone replacement therapy (GHRT) is effective versus placebo in the improvement of Quality of Life i…

Adult Growth Hormone DeficiencyMild Traumatic Brain Injury

Estimated

~$50 – $1,350

Actual pay is set by the research site.

VA Office of Research and DevelopmentNCT04867317

The Phenotype and Etiology of Proteus Syndrome

This study will examine rare congenital disorders that involve malformations and abnormal growth. It will focus on patients with Proteus syndrome, whose physic…

Proteus SyndromePIK3CA Related Overgrowth Spectrum

Estimated

~$10 – $675

Actual pay is set by the research site.

National Human Genome Research Institute (NHGRI)NCT00001403

Phase 2

Study Assessing the Efficacy, Safety and Pharmacokinetics of Alpelisib in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)

This study is designed to demonstrate the efficacy and assess safety and tolerability of oral daily alpelisib in participants with PIK3CA-related overgrowth sp…

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Novartis PharmaceuticalsNCT06997588

Phase 1

Biologic Association Between Metabolic MR-PET and Tissue Measures of Glycolysis in Brain Tumors Visualization, Quantitation, and Targeting of Infiltrating Glioblastoma Cells With pH Sensitive Amine Chemical Exchange Saturation Transfer Magnetic Resonance Imaging-KL2TR001882

The purpose of this project is to validate a new combined MRI and PET imaging technique as a biomarker or measure of glycolysis in brain tumors. To accomplish …

Glioblastoma MultiformeGlycolytic IndexEpidermal Growth Factor Receptor

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Jonsson Comprehensive Cancer CenterNCT06059690

A Multi-Site, Prospective, Two-Part Longitudinal, Observational Cohort Study Of Pregnant Women To Evaluate Biomarkers For Prediction Of Pregnancy Complications

ASPIRE will be a multi-site, prospective, two-part longitudinal, noninterventional observational cohort study of nulliparous singleton pregnant women to evalua…

GDMPreterm PreeclampsiaPreeclampsia+2 more

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Medicines360NCT07669935

Phase 2

FORAY: A Phase 2, Randomized, Open-Label Study Evaluating Vepugratinib in Adults With FGFR3 Altered Low Grade, Intermediate Risk, Non-muscle Invasive Bladder Cancer and Low Grade Upper Tract Urothelial Carcinoma

The main purpose of this study is to see how well vepugratinib works in adults with low grade, intermediate risk, non-muscle invasive bladder cancer (LG IR NMI…

Urinary Bladder NeoplasmsUrologic NeoplasmsReceptor, Fibroblast Growth Factor, Type 3

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Eli Lilly and CompanyNCT07827612